Yasuhiko Iino Selected Research

Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)

8/2003	Growth hormone receptor variant (L526I) modifies plasma HDL cholesterol phenotype in familial hypercholesterolemia: intra-familial association study in an eight-generation hyperlipidemic kindred.
1/2003	Apolipoprotein H variant modifies plasma triglyceride phenotype in familial hypercholesterolemia: a molecular study in an eight-generation hyperlipidemic family.
1/2002	Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhiko Iino Research Topics

Disease

12	Proteinuria 02/2022 - 09/2003
8	Chronic Renal Insufficiency 10/2015 - 09/2003
6	Nephrotic Syndrome (Syndrome, Nephrotic) 02/2022 - 03/2003
5	Chronic Kidney Failure (Chronic Renal Failure) 02/2022 - 09/2002
4	Glomerulonephritis 12/2012 - 01/2005
3	Hypertension (High Blood Pressure) 10/2015 - 09/2003
3	Thrombotic Microangiopathies 05/2013 - 01/2011
3	Hematuria 01/2013 - 01/2005
3	IGA Glomerulonephritis (IGA Nephropathy) 01/2013 - 01/2011
3	Virus Diseases (Viral Diseases) 12/2012 - 01/2011
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2012 - 09/2002
3	Hypercholesterolemia 12/2007 - 01/2004
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 08/2003 - 01/2002
2	Isolated Systolic Hypertension 10/2015 - 09/2003
2	Hyperlipidemias (Hyperlipidemia) 06/2015 - 05/2015
2	Heart Failure 12/2012 - 01/2012
2	Hemorrhage 11/2012 - 10/2011
2	Anemia 10/2011 - 02/2010
2	Peritonitis 12/2010 - 04/2010
2	Renal Insufficiency (Renal Failure) 10/2007 - 09/2004
1	Dyslipidemias (Dyslipidemia) 06/2015
1	Hypoproteinemia 06/2015
1	Peripheral Arterial Disease 01/2014
1	Malignant Hypertension 05/2013
1	Brain Edema (Cerebral Edema) 05/2013
1	Anuria 05/2013
1	Acne Vulgaris 01/2013
1	Immune System Diseases (Immune Disorders) 12/2012
1	Erythema Infectiosum (Fifth Disease) 12/2012
1	Vasculitis (Vasculitides) 11/2012
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 11/2012
1	Multiple Pulmonary Nodules 11/2012
1	Fibrosis (Cirrhosis) 08/2012
1	Ureteral Obstruction 08/2012
1	Hepatitis C 06/2012
1	Acute Kidney Injury (Acute Renal Failure) 01/2012
1	Ischemia 01/2012
1	Bronchiolitis Obliterans Syndrome 09/2011
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2011
1	Ascites 01/2011
1	Amyloidosis 01/2011
1	Eosinophilia 01/2011
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2011

Drug/Important Bio-Agent (IBA)

6	oxidized low density lipoproteinIBA 02/2022 - 01/2002
4	Pharmaceutical PreparationsIBA 02/2022 - 10/2007
4	CreatinineIBA 05/2013 - 09/2003
3	LDL Lipoproteins (beta Lipoproteins)IBA 02/2022 - 01/2002
3	Antihypertensive Agents (Antihypertensives)IBA 10/2015 - 09/2003
3	Angiotensin Receptor AntagonistsIBA 10/2015 - 09/2003
3	Losartan (Cozaar)FDA LinkGeneric 10/2015 - 09/2003
3	Proteins (Proteins, Gene)FDA Link 10/2015 - 09/2003
3	Amlodipine (Norvasc)FDA LinkGeneric 10/2015 - 09/2003
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2015 - 09/2003
3	SteroidsIBA 01/2013 - 01/2011
3	Hemoglobins (Hemoglobin)IBA 12/2012 - 02/2010
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2012 - 09/2004
3	CytokinesIBA 01/2011 - 02/2007
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2015 - 03/2002
2	Urea (Carbamide)FDA LinkGeneric 05/2013 - 01/2011
2	NitrogenIBA 05/2013 - 01/2011
2	mizoribineIBA 01/2013 - 02/2011
2	Immunoglobulins (Immunoglobulin)IBA 12/2012 - 06/2012
2	Darbepoetin alfa (Aranesp)FDA Link 12/2012 - 02/2010
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 08/2012 - 01/2012
2	Matrix Metalloproteinases (MMPs)IBA 08/2012 - 01/2012
2	P-SelectinIBA 01/2012 - 02/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2010 - 02/2007
2	Dialysis SolutionsIBA 04/2010 - 12/2006
2	Lipoproteins (Lipoprotein)IBA 12/2007 - 08/2003
2	Triglycerides (Triacylglycerol)IBA 01/2003 - 01/2003
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 10/2015
1	DiureticsIBA 10/2015
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 10/2015
1	Enalapril FDA LinkGeneric 10/2015
1	polyacrylonitrile (Orlon)FDA Link 01/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2013
1	Immunoglobulin G (IgG)IBA 12/2012
1	HematinicsIBA 12/2012
1	Minocycline (Cyclops)FDA LinkGeneric 08/2012
1	VimentinIBA 08/2012
1	HSP47 Heat-Shock Proteins (Heat Shock Protein 47)IBA 08/2012
1	CollagenIBA 08/2012
1	imidaprilIBA 01/2012
1	AdiponectinIBA 01/2012
1	olmesartanIBA 01/2012
1	ZincIBA 01/2012
1	EndopeptidasesIBA 01/2012
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2012
1	Cinacalcet (Sensipar)FDA Link 10/2011
1	Methylprednisolone FDA LinkGeneric 02/2011
1	Calcineurin InhibitorsIBA 01/2011
1	Immunoglobulin A (IgA)IBA 01/2011
1	EndotoxinsIBA 01/2011

Therapy/Procedure

12	Therapeutics 10/2015 - 12/2002
9	Renal Dialysis (Hemodialysis) 01/2014 - 09/2002
4	Blood Component Removal (Apheresis) 02/2022 - 02/2007
2	Tonsillectomy 01/2013 - 02/2011
2	Hematopoietic Stem Cell Transplantation 09/2011 - 01/2011
1	Aftercare (After-Treatment) 06/2015
1	X-Ray Film 11/2012